We are committed to providing high-quality, ethical solutions that aim improve the lives of Parkinson’s disease patients, educate the healthcare community and provide practical assistance in treatment scenarios
One of the key issues for healthcare professionals is how to accurately identify WHEN a patient needs to move from standard treatments to a more complex and bespoke solution.
Historically, patients (who are often elderly and have other health issues) are moved too late. Indeed, a vast number of patients never receive the benefits of non-oral medication, instead staying on increasingly-strong oral regimes long beyond the time it ceases to be effective.
Our goal has always been to produce products and technology that increases the length of time patients are “ON” – meaning their symptoms are controlled rapidly and reliably, and they are able to go about their daily lives with confidence.
Greenyard Pharmaceutical remains committed to making breakthroughs not only in the products we develop, but also in the support patients receive and the value we deliver to our payers and prescribers.
As well as the Greenyard Pharmaceutical nurse team, we provide a 24/7 customer helpline for our product users to help ensure our delivery devices are working correctly and healthcare providers and patients have the support they need.
Parkinson’s disease is a progressive neurological condition. It is the second most common age-related neurodegenerative disorder after Alzheimer’s disease.1
The symptoms of Parkinson’s disease are caused by a loss of dopaminergic neurons in the brain which leads to a lack of dopamine. Dopamine is a neurotransmitter which is involved in coordinating movement, which is why Parkinson’s often causes problems like shaking, rigidity and difficulty walking.
There is currently no cure for Parkinson’s disease, with treatments focussing on improving and controlling symptoms.